Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277082 · ClinicalTrials.gov registry record
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 24
- Enrollment target
NCT00277082: Completed study, sponsored by University of New Mexico.
NCT00277082 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00277082 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time. 1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison to venous and urine concentrations. 1.3. To determine the tumor concentration of 9NC administered by inhalation
Interventions
- DRUG 9-NC in aerosol reservoir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-06 |
What the finished NCT00277082 record still lists
NCT00277082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 9-NC in aerosol reservoir is the first listed.
NCT00277082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00277082 about?
NCT00277082 is a clinical study titled "Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung". To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time. 1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison to venous and urine concentrations. 1.3. To determine the tumor concentration of 9NC administered by inhalation
What is the current status of trial NCT00277082?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2003-08. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00277082?
The interventions under investigation include: 9-NC in aerosol reservoir (DRUG).
Who is sponsoring clinical trial NCT00277082?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia